Exagen: Chet Burrell, Tina Nova, Bruce Robertson
San Diego, California-based Exagen has appointed Chet Burrell, Tina Nova, and Bruce Robertson to its board of directors.
Burrell has held several CEO-level positions and chairmanship roles in the US for nearly 40 years. He currently serves as managing member of Sivalon Healthcare Holdings.
Nova serves as president and CEO of Decipher Biosciences, in additon to chair of the board of directors for Arena Pharmaceuticals and a member of the board of directors at Veracyte. Prior to Decipher, Nova was president and CEO of Molecular Stethoscope and served as senior VP and general manager of Illumina's oncology business unit. In addition, Nova was a founder of Genoptix (which was acquired by Novartis in 2011), where she served as president and CEO from 2000 to 2014. Prior to Genoptix, Nova was a cofounder of Novagen, and servied as its chief operating officer and president from 1994 to 2000. Before Novagen, she served as COO of Selective Genetics.
Robertson currently serves as managing director of H.I.G. BioHealth Partners. Prior to H.I.G., he served as managing director at Toucan Capital. Before Toucan, Robertson was director of business development at IGEN international.